avonex and multiple sclerosis

LOWER LIMBS ALMOST STOPPED WORKING, STIFFNESS IN BODY AND URINE N STOOL CONTROL FINISHED. I M TAKING AVONEX ONCE A WEEK. THIS SITUATION IS SINCE 10 JUN 2012. I HAVE BEEN ADVISED TYSABR. S IT OK? PLEASE HELP ME REGAIN SOME OF MY STRENGTH.

But worldwide the accepted treatment would be for you to have a disease modifying drug - at present there are four standard ones - Copaxone, Rebif, Avonex, and Betaseron. All of these are injections. They may or may not help to slow the progrression of your disease. There are new drugs beings worked with too - one is Tysabri, which is an intravenous drug that is given monthly. You might ask about that. We have some members here who got worse and would not walk, but now can walk.

//www.medhelp.org/posts/Multiple-Sclerosis/Gilenya-Users-Past-and-Present/show/1469412 http://www.medhelp.org/posts/Multiple-Sclerosis/Copaxone-users---past-and-present/show/643683 http://www.medhelp.org/posts/Multiple-Sclerosis/Tysabri-Users---Past-and-Present/show/1569374 http://www.medhelp.org/posts/Multiple-Sclerosis/Aubagio-Users-Past-and-Present/show/1946899 http://www.medhelp.org/posts/Multiple-Sclerosis/Our-Tysabri-Users---Past-and-Present/show/658918 http://www.medhelp.

//www.themcfox.com/multiple-sclerosis/ms-drugs/avonex/avonex-blood-counts.htm updated 2004, it might be worth finding out if your having a negative reaction and need to change DMD.

//www.medhelp.org/posts/Multiple-Sclerosis/DMD-Users-Past--Present---Copaxone--Rebif--Avonex--Betaseron--Tysabri--other/show/1193746 http://www.medhelp.org/posts/Multiple-Sclerosis/DMD/show/1041491 http://www.medhelp.org/posts/Multiple-Sclerosis/DMDs-experiences-please/show/759170 http://www.medhelp.org/posts/Multiple-Sclerosis/For-those-of-you-on-one-of-the-disease-modifying-drugs/show/471258 You may fair well with side affects.

Copaxone, Rebif, Avonex, and Betaseron. Other medications are used (like the Solu-Medrol) during attacks, and to help with symptoms (like Provigil for fatigue). There are other medications that are used when the CRAB drugs aren't working, but have risks and side effects (like Tysabri). On this site, there's a lot of information about medication and treatment, relapses, and pseudo-relapses, etc. in the Health Pages (see upper right hand corner).

We study 61 people who have Lipoma and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take. You are not alone: join a support group for people who have Multiple sclerosis and Lipoma .. This is just one of many that have lipomas with MS . So there is definitely an association.

Hello, I have been previously diagnosed by an ms specialist with relapsing remitting multiple sclerosis in 2002, another neurologist diagnosed me with ms in 2003, and in between have been hospitalized many times since then for acute ms attacks, and most of the time optic neuritis was a presenting symptom. I was wondering why my current, new neurologist in 2010, wanted to rule out amyotrophic lateral sclerosis with an emg test.

Thanks for posting this. I am going to find out more about it.

//www.medhelp.org/posts/Multiple-Sclerosis/Our-Tysabri-Users---Past-and-Present/show/658918 http://www.medhelp.

Nevine, welcome to the MS forum. Wow, you live in Egypt--a place that I would love to one day visit! MS is very unpredictable, so it's hard to say how long an attack will last. First attacks will sometimes be very hard and last for several weeks or even months, but this is so variable. Also, attack times will even vary in the person themselves. My last attack only lasted a couple of days. However, I've had attacks that have lasted several months.

org/posts/Multiple-Sclerosis/DMD-Users-Past--Present---Copaxone--Rebif--Avonex--Betaseron--Tysabri--other/show/1193746 -Shell

org/posts/Multiple-Sclerosis/avonex-pen-has-anyone-heard-anything-about-it/show/1729510#post_7998927

Two attacks and clinical evidence of one lesion. One attack and clinical evidence of two separate lesions. One attack, clinical evidence of one lesion, and paraclinical evidence of another separate lesion. Laboratory supported probable multiple sclerosis: Two attacks and CSF abnormalities. In each of these above situations and attack is defined by neurologic symptoms and signs lasting more than 24 hours. Second attack must be separated by the first by at least one month.

002 Long-Term Safety and Efficacy and Association Between Baseline Treatment History and Postbaseline Relapses in Multiple Sclerosis Patients Treated with Natalizumab in the TYSABRI Observational Program (TOP) – Poster P04.134 Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) – First Results from the TYNERGY Trial – Poster P07.

Interferon Drugs for Multiple Sclerosis (Avonex, Betaseron, Rebif)Interferon beta drugs help control the immune system, which helps control MS. Glatiramer Glatiramer helps prevent the body's immune system from attacking nerve fibers. Novantrone Novantrone slows disability and reduces the relapse rate. Tysabri Therapy Tysabri reduces the relapse rate, but is somewhat controversial. Aubagio Aubagio reduces the number of flares in adults with relapsing forms of multiple sclerosis.

New preclinical data presented at European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS) in Prague suggests that FTY720 (fingolimod) directly reduces neurodegeneration and enhances repair of the central nervous system (CNS) damage caused by multiple sclerosis (MS) by interacting with sphingosine-1-phosphate receptors (S1P-R) expressed on brain cells.

//www.medhelp.org/tags/show/7687/Multiple-Sclerosis?

I find a source online that says in 2008 Avonex was Rs 9,000 per vial. Please call your Multiple Sclerosis Society of India (MSSI) and see what advice they can share. People on avonex have very good luck with slowing their disease, I hope you will do well on it, too!

16 Apr 2009 - 3:00 PDT www. medicalnewstoday .com/articles/146211.php Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed neurologists anticipate that less than 30 percent of their use of emerging oral agents --- Merck Serono's oral cladribine, Novartis/Mitsubishi Pharma's fingolimod (FTY-720) --- for the treatment of multiple sclerosis will be in the first line.

Avonex and multiple sclerosis

Common Questions and Answers about Avonex and multiple sclerosis

avonex